ArticleEnvironment international2026
Does the timing of sample collection confound the association between prenatal serum PFAS concentrations and birthweight: results from two prospective cohort studies.
Article in Environment international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundMaternal serum concentrations of per- and polyfluoroalkyl substances (PFAS) during pregnancy have been consistently associated with reduced birthweight. However, these associations may be confounded by the timing of sample collection due to pregnancy-related changes in pharmacokinetics that impact both serum PFAS concentrations and birthweight.
methodsWe measured nine serum PFAS concentrations in each trimester among 728 women in the MABC Study (Ma'anshan, China, enrolled 2013-2014). We estimated covariate-adjusted differences in birthweight for individual PFAS and their mixture, as well as percent change in PFAS by infant birthweight. We repeated our analyses in 70 women-infant dyads from the HOME Study (Cincinnati, Ohio, enrolled 2003-2006) with repeated PFAS measures in 2nd trimester and at delivery.
resultsAssociations of individual PFAS and their mixture with birthweight became more strongly inverse for measurements taken later in pregnancy. Each SD increase in log
conclusionsThese findings suggest that physiological changes in pregnancy may confound associations between serum PFAS and birthweight. Studies with PFAS measures later in pregnancy may overestimate the true effect of PFAS on fetal growth.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.